Literature DB >> 24990596

Successful co-administration of dabigatran etexilate and protease inhibitors ritonavir/lopinavir in a patient with atrial fibrillation.

Stefano Barco1, Michiel Coppens, Erik-Jan van den Dool, Daan van de Kerkhof, An K Stroobants, Saskia Middeldorp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24990596     DOI： 10.1160/TH14-03-0214

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  7 in total

Review 1.  A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products.

Authors:  Andrew Stolbach; Karolina Paziana; Harry Heverling; Paul Pham
Journal:  J Med Toxicol       Date:  2015-09

Review 2.  Cobicistat Versus Ritonavir: Similar Pharmacokinetic Enhancers But Some Important Differences.

Authors:  Alice Tseng; Christine A Hughes; Janet Wu; Jason Seet; Elizabeth J Phillips
Journal:  Ann Pharmacother       Date:  2017-06-19       Impact factor: 3.154

3.  Ritonavir-Boosted Protease Inhibitors but Not Cobicistat Appear Safe in HIV-Positive Patients Ingesting Dabigatran.

Authors:  Payal P Kakadiya; Patricia Pecora Fulco; Robert T Higginson
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 4.  Prevention of stroke in people living with HIV.

Authors:  Ivy Nguyen; Anthony S Kim; Felicia C Chow
Journal:  Prog Cardiovasc Dis       Date:  2020-01-31       Impact factor: 8.194

Review 5.  Drug-drug interactions with candidate medications used for COVID-19 treatment: An overview.

Authors:  Haleh Rezaee; Fariba Pourkarim; Samira Pourtaghi-Anvarian; Taher Entezari-Maleki; Touraj Asvadi-Kermani; Masoud Nouri-Vaskeh
Journal:  Pharmacol Res Perspect       Date:  2021-02

Review 6.  Lopinavir-Ritonavir in SARS-CoV-2 Infection and Drug-Drug Interactions with Cardioactive Medications.

Authors:  Shubham Agarwal; Sanjeev Kumar Agarwal
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-12       Impact factor: 3.727

Review 7.  Stroke and Systemic Thromboembolism Prevention in People Living With Human Immunodeficiency Virus With Atrial Fibrillation: A Review of Its Implications for Clinical Practice.

Authors:  Pilar Vizcarra; Silvia Guillemi; Oghenowede Eyawo; Robert S Hogg; Julio S Montaner; Matthew Bennett
Journal:  CJC Open       Date:  2019-07-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.